Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2010
09/29/2010CN101843634A Biocompatible dialysis fluids containing icodextrins
09/29/2010CN101843601A Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
09/29/2010CN101843579A 5-hydroxymethyl Tolterodine gel preparation and preparation method thereof
09/29/2010CN101698066B Chinese medicine preparation capable of diminishing inflammation, relieving pains, resisting bacteria, expelling stone and benefiting gallbladder, and preparation method and applications thereof
09/29/2010CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition
09/29/2010CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease
09/29/2010CN101269139B Medicine for treating nephritis type haematuria
09/29/2010CN101244227B Chinese medicine pill mainly for treating nephropathy
09/29/2010CN101244060B Leonurus heterophyllus alkaloid composition
09/29/2010CN101054414B Method of extracting and preparing deer DGF
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803562 Method for screening human intestinal Npt2B modulatory agents
09/28/2010CA2553160C 2-heteroaryl-substituted benzimidazole derivative
09/28/2010CA2448038C Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106871A1 Osmotic pressure-controlling agent
09/23/2010WO2010106519A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010WO2010088839A8 Drug membrane sticking to pants for treating prostatic hyperplasia and chronic prostatitis, and process for preparation thereof
09/23/2010US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/23/2010US20100240748 Tetrahydronaphthalen-2-ol derivatives
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240710 Use of Pyridoxamine to Treat and/or Prevent Disease Processes
09/23/2010US20100240702 Benzimidazolone Chymase Inhibitors
09/23/2010US20100240697 Pharmaceutical composition for treating overactive bladder
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors
09/23/2010US20100240636 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240620 3-Cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases
09/23/2010US20100240598 Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologies
09/23/2010US20100239685 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same
09/23/2010US20100239673 Blood compatible nanomaterials and methods of making and using the same
09/23/2010US20100239670 Topical Composition Method for Treating Urinary Stress Incontinence
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239583 Antibodies against flagellin and uses thereof
09/23/2010US20100236958 Radiopharmaceutical composition
09/23/2010CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010CA2755697A1 Amide derivative
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229387A1 Process for preparing chemically and chirally pure solifenacin base and its salts
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010CN201586233U Fuyankang soft capsule
09/22/2010CN1856484B Therapeutic agents useful for treating or preventing pain
09/22/2010CN101842096A Film-coated preparation
09/22/2010CN101838277A Cefotetan disodium hydrate and preparation method and application thereof
09/22/2010CN101837108A Liver and kidney yin-nourishing soup
09/22/2010CN101837100A Medicinal composition for curing gynecopathy and application thereof
09/22/2010CN101837098A Novel kidney-healing particle medicinal composition
09/22/2010CN101837076A Chinese medicinal composition preparation, preparation method and quality detection method
09/22/2010CN101837070A Preparation method for medlar radix rehmanniae wine
09/22/2010CN101837067A Medicinal composition for curing gynecological diseases and preparation method thereof
09/22/2010CN101837014A Medicinal composition for treating chronic kidney diseases
09/22/2010CN101190321B Proprietary Chinese medicine preparations for treating uric acid nephropathy and preparation method thereof
09/22/2010CN101057677B Xinxi nutrient supplement
09/22/2010CN100998689B Traditional Chinese medicine preparation for treating chronic nephritis, kidney failure
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799816 N-[2,3-Dibromo-4-(4,5-dihydro-1H-imidazol-2-ylmethyl)-5-fluoro-phenyl]-methanesulfonamide, an alpha-1A adrenergic receptor agonist, used for the treatment of incontinence
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
09/21/2010US7799529 Nephrin gene and protein
09/21/2010CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/16/2010WO2010104973A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104945A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010WO2010104176A1 Mega-phosphoprotein cleavage inhibitor
09/16/2010WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
09/16/2010WO2010068287A8 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/16/2010US20100234599 Method for preparing acid addition salts of polyacidic basic compounds
09/16/2010US20100234473 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines
09/16/2010US20100234429 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010US20100234427 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
09/16/2010US20100234421 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/2010US20100234418 Compounds and uses thereof
09/16/2010US20100234386 Quinoxaline derivatives as pi3 kinase inhibitors
09/16/2010US20100234382 Composition comprising a pde4 inhibitor and a pde5 inhibitor
09/16/2010US20100234372 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 562